Talimogene laherparepvec: First in class oncolytic virotherapy

por Conry, Robert M., Westbrook, Brian, McKee, Svetlana, Norwood, Timothy Graham
Publicado 2018

Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab

por Kropp, Lauren M., De Los Santos, Jennifer F., McKee, Svetlana B., Conry, Robert M.
Publicado 2016

Talimogene laherparepvec induces durable response of regionally advanced Merkel cell carcinoma in 4 consecutive patients

por Westbrook, Brian C., Norwood, T. Graham, Terry, Nina L.J., McKee, Svetlana B., Conry, Robert M.
Publicado 2019

Primary Intraosseous Smooth Muscle Tumor of Uncertain Malignant Potential: Original Report and Molecular Characterization

por Kropp, Lauren, Siegal, Gene P., Frampton, Garrett M., Rodriguez, Michael G., McKee, Svetlana, Conry, Robert M.
Publicado 2016

Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years

por Norwood, Timothy G., Lenneman, Carrie A., Westbrook, Brian C., Litovsky, Silvio H., McKee, Svetlana B., Conry, Robert M.
Publicado 2020

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

por Blackmon, Jonathan T., Stratton, Michael S., Kwak, Young, Pavlidakey, Peter G., Slominski, Andrzej T., McKee, Svetlana B., Viator, Toni M., Kim, Ju Young, Huang, Conway C., Conry, Robert M.
Publicado 2017

Smoldering myocarditis following immune checkpoint blockade

por Norwood, Timothy G., Westbrook, Brian C., Johnson, Douglas B., Litovsky, Silvio H., Terry, Nina L., McKee, Svetlana B., Gertler, Alan S., Moslehi, Javid J., Conry, Robert M.
Publicado 2017